But some in the pharmaceutical industry believe members of Congress will draw a distinction between drugs for the treatment of AIDS, malaria and tuberculosis, and those for other diseases such as cancer or heart disease. ???How can a chronic, slow-acting, non-contagious condition be considered a public-health crisis???? asked one lobbyist.